A Numb Skin Eruption
Am Fam Physician. 1999 Nov 1;60(7):2087-2088.
A 23-year-old man presented with a five-month history of a slightly pruritic eruption on his right elbow (see the accompanying figure). He had taken a 15-day course of itraconazole (Sporanox), in a dosage of 200 mg per day, and had applied econazole (Spectazole) cream twice a day for 15 days and ketoconazole (Nizoral) cream twice a day for one month without improvement. He noted that his skin felt numb in the area of the eruption.
On physical examination, the patient was found to have a 25 cm × 20 cm annular plaque with an indurated border and some central clearing on the right antecubital fossa.
Which one of the following does this condition represent, given the patient's history and physical appearance on examination?
A. Granuloma annulare.
B. Hansen's disease.
C. Mycosis fungoides.
E. Tinea corporis.
The answer is B: Hansen's disease. A skin biopsy showed tuberculoid leprosy. The patient was treated with dapsone, 100 mg per day, and rifampin, 600 mg per month for six months.
Hansen's disease is a chronic granulomatous disease caused by Mycobacterium leprae that affects the skin and nerves.1 It is estimated that 1.15 million cases exist worldwide; in the United States, southern Louisiana and Texas are considered endemic for leprosy.2,3 The mode of transmission is postulated to be through the nasal mucosa of untreated persons with leprosy and may also involve direct skin-to-skin contact, as well as exposure to the nine-banded armadillo.3,4
Clinically, two helpful features are a cutaneous eruption and areas of cutaneous anesthesia.1 Other features are nerve enlargement, nasal stuffiness, inflammatory eye changes and loss of lateral eyebrows.5 Depending on the immune response of the host, leprosy can manifest in several different ways, ranging from tuberculoid to lepromatous leprosy, including indeterminate and borderline types.3 Tuberculoid leprosy, as in this patient, usually presents as a single sharply demarcated, hypopigmented, hypoesthetic macule with a circinate, elevated border. Often the nerves at the edge of the lesion are thickened, and peripheral nerves can be enlarged.1 Lepromatous leprosy is more generalized, involving the skin, upper respiratory mucosal membranes, reticuloendothelial system, adrenal glands and testes. Lesions are small, ill-defined, bilaterally symmetric, flesh-colored, erythematous or slightly hypopigmented macules, which progress to papules, plaques, nodules and diffuse thickening of the skin.3
Complications of leprosy include severe neuritic pain, contractures and crippling of the hands and feet, neuropathic plantar ulcers, secondary infections, complete nasal obstruction, saddlenose deformity, scarring of the testes resulting in infertility, and blindness.1,5
Diagnosis is made by demonstrating leprosy bacilli in the skin. It is preferable to get a skin biopsy from the affected area and a special stain (such as the Fite stain, a modified acid-fast stain) for leprosy must be requested.3 Because of high resistance worldwide, the World Health Organization recommends multidrug therapy: three drugs for treatment of lepromatous leprosy limited to five years (dapsone, 100 mg per day; rifampin, 600 mg per month; and clofazimine (Lamprene), 50 mg per day.4 Tuberculoid leprosy is treated with dapsone, 100 mg per day, and rifampin, 600 mg per month, for six months.3,5
The other choices (granuloma annulare, mycosis fungoides, sarcoidosis and tinea corporis) may also present as one or more annular plaques, similar to those seen in leprosy. A potassium hydroxide mount of the skin scrapings of tinea corporis would reveal numerous hyphae, thus differentiating it from the other disorders. In this patient, the history of no improvement after treatment with topical and oral antifungal agents would make tinea corporis an unlikely diagnosis. His complaint of numbness in the area of the lesions is a clue for the diagnosis of leprosy. Because all of these disorders can look similar clinically, a skin biopsy is necessary to make a definitive diagnosis.
REFERENCESshow all references
1. Fitzpatrick TB, et al. Color atlas and synopsis of clinical dermatology: common and serious diseases. 3d ed. New York: McGraw-Hill, 1997:658–63....
2. Trautman JR. The history of leprosy. In: Hastings RC, Diltor VA, eds. Leprosy. 2d ed. New York: Churchill Livingstone, 1994:11–25.
3. Golitz LE. Leprosy (Hansen's disease). In: Fitzpatrick JE, Aeling J. Dermatology secrets. Philadelphia: Hanley and Belphus, 1996:188–94.
4. Ell SR. Leprosy in history. In: Hastings RC, Diltor VA, eds. Leprosy. 2d ed. New York: Churchill Livingstone, 1994:3–10.
5. Miller RA. Leprosy (Hansen's disease). In: Fauci AS, et al. Harrison's Principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:1014–9.
The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at https://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. E-mail submissions to firstname.lastname@example.org.
Copyright © 1999 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Jan 15, 2020
Access the latest issue of American Family Physician